Your browser doesn't support javascript.
loading
Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections.
Venge, Per; Håkansson, Lena Douhan; Garwicz, Daniel; Peterson, Christer; Xu, Shengyuan; Pauksen, Karlis.
Afiliación
  • Venge P; Department of Medical Sciences, Sections of Clinical Chemistry, Uppsala University, Uppsala, Sweden. Electronic address: per.venge@medsci.uu.se.
  • Håkansson LD; Department of Medical Sciences, Sections of Clinical Chemistry, Uppsala University, Uppsala, Sweden.
  • Garwicz D; Department of Medical Sciences, Sections of Clinical Chemistry, Uppsala University, Uppsala, Sweden.
  • Peterson C; Department of Medical Sciences, Sections of Clinical Chemistry, Uppsala University, Uppsala, Sweden.
  • Xu S; Department of Medical Sciences, Sections of Clinical Chemistry, Uppsala University, Uppsala, Sweden.
  • Pauksen K; Department of Infectious Diseases, Uppsala University, Uppsala, Sweden.
J Immunol Methods ; 424: 85-90, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26002155
UNLABELLED: The distinction between causes of acute infections is a major clinical challenge. Current biomarkers, however, are not sufficiently accurate. Human neutrophil lipocalin (HNL) in serum distinguishes acute infections with high accuracy, but in the emergency setting the assay time should be <15-20min, which excludes the use of serum samples. The aim was therefore to develop a novel rapid assay principle and test its clinical performance. METHODS: Serum and neutrophils obtained from 84 infected and 20 healthy subjects were used in the experimental study. 725 subjects (144 healthy controls and 581 patients with signs and symptoms of acute infections) were included in the clinical study. HNL was measured in EDTA-plasma by ELISA or in heparinized whole blood after fMLP activation by a prototype point-of-care assay. RESULTS: Increased release of HNL from neutrophils after activation with fMLP was seen already after 5 min incubation. The release of HNL from purified neutrophils after 15 min incubation with fMLP was significantly correlated to the HNL concentrations in serum obtained from the same patient (r = 0.74, p < 0.001). In the distinction between healthy controls and patients with bacterial infections, the areas under the ROC-curves were 0.95 (95% CI 0.91-0.97) and 0.88 (95% CI 0.84-0.91) for HNL in fMLP-activated whole blood and EDTA-plasma, respectively, (p < 0.001) and in the distinction between bacterial and viral infections 0.91 (95% CI 0.86-0.95) and 0.76 (95% CI 0.70-0.81), respectively (p < 0.001). CONCLUSION: The clinical performance of HNL in fMLP-activated whole blood was superior to HNL in EDTA-plasma and similar to HNL in serum. The procedure can be adopted for point-of-care testing with response times of <15 min.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Virosis / Lipocalinas / Neutrófilos Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunol Methods Año: 2015 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Virosis / Lipocalinas / Neutrófilos Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunol Methods Año: 2015 Tipo del documento: Article Pais de publicación: Países Bajos